How we measure 'reads'
A 'read' is counted each time someone views a publication summary (such as the title, abstract, and list of authors), clicks on a figure, or views or downloads the full-text. Learn more
DR ANTHONY MELVIN CRASTO, Worlddrugtracker, PhD from ICT,1991, Mumbai, India, in Organic chemistry, He is working with GLENMARK PHARMA LTD, as Principal Scientist, Process researchHe worked with major multinationals like Hoechst Marion Roussel, now Sanofi, Searle India ltd, now RPG lifesciences. He suffered a paralytic stroke in dec2007 and is bound to a wheelchair, this seems to have injected feul in him to help chemists around the world, he is more active than before and is pushing boundaries
May 2003 - December 2005
Innovassynth Technologies (I) Ltd.
- Sr Manager R&D or Group principal scientist
- led a team of 30 chemists for the custom synthesis business in the area of drugs, organic intermediates, speciality chemicals, flavours and fragrances, nutraceuticals and mettalocenes. (25 projects) customers were Sandoz Basel, BASF Germany,
October 1997 - May 2003
- Manager, research and development, API,RPG Life sciences ltd (formerly American multinational SEARLE
- All round process development and commercialization of several molecules
API Process Research Overview by Dr Anthony Crasto
Manufacturing Presentation by Anthony Melvin Crasto
Drug discovery overview by DR ANTHONY MELVIN CRASTO
How to Handle Drug Polymorphs... Case Study of Trelagliptin Succinate
Flavors and fragrances review
How to handle drug polymorphs... case study of trelagliptin succinate
SCALEUP TECHNIQUES AND PILOT PLANT IN DRUG INDUSTRY
Method for preparation of dronedarone via palladium-catalyzed hydrogenation and methanesulfonylation
Method for preparation of 2, 3-diaryl-5-substituted pyridines and their intermediates http://patentscope.wipo.int/search/en/detail.jsf?docId=WO2011158250&recNum=4&docAn=IN2011000388&queryString=%28%28&
The present invention relates to amorphous form of bazedoxifene acetate and a process for the preparation thereof.
The present invention provides a process for the preparation of Atovaquone in a pure polymorphic form characterized by an X-ray powder diffraction pattern with peaks at about 7.0, 9.7, 14.2, 14.8, 17.0, 19.2, 20.4, 22.1, 22.7, 26.9 and 28.7�0.2 degrees 2 theta comprising: a) providing a solution of atovaquone in aprotic polar solvent b) adding a su...
IMPROVED PROCESS FOR THE PREPARATION OF TADALAFIL,A process for the preparation of (6R,12aR)-2,3,6,7,12,12a-hexahydro-2methyl-6-(3,4-methylenedioxyphenyl)pyrazino1’,2’;1,6pyrido3,4-bindole-1,4-dion of Formula I: the process comprising cyclizing a ...